SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-180657
Filing Date
2021-06-03
Accepted
2021-06-03 08:06:05
Documents
13
Period of Report
2021-06-02
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d190548d8k.htm   iXBRL 8-K 32857
  Complete submission text file 0001193125-21-180657.txt   210883

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrk-20210602.xsd EX-101.SCH 5116
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20210602_def.xml EX-101.DEF 14771
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20210602_lab.xml EX-101.LAB 24865
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20210602_pre.xml EX-101.PRE 15934
6 EXTRACTED XBRL INSTANCE DOCUMENT d190548d8k_htm.xml XML 9415
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 21991253
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences